SAKAR HEALTHCARE
SAKAR · NSE
946.50
-42.50 (-4.30%)
as of 29 Oct 2026 close
Open
980.20
High
993.90
Low
936.00
Prev close
989.00
52w high
1,229.85
23 Sept 2026
52w low
352.05
29 Oct 2025
VWAP
958.83
Delivery %
46.9%
of volume
Volume 1.01 L · turnover ₹9.64 Cr · NSE bhavcopy (official close) · history since 14 Oct 2016
- ISIN
- INE732S01012
- Series
- EQ
- Listed on NSE
- 11 Apr 2019
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Quarterly results · Standalone · latest 30 Sept 2026
filed 23 Oct 2026, 12:27 pm IST| ₹ crore | Sept 26* |
|---|---|
| Revenue | 87 |
| Other income | 0 |
| Total expenses | 72 |
| Operating margin | 27.8% |
| Finance costs | 2 |
| Depreciation | 7 |
| Profit before tax | 16 |
| Tax | 5 |
| Net profit | 11 |
| Net margin | 12.9% |
| EPS (₹) | 5.08 |
Source and definitions
NSE financial-results filings (XBRL / integrated filing). Figures exactly as filed with NSE in the company's results, converted to ₹ crore from the filing's own rounding. Operating margin = (PBT + finance costs + depreciation − other income) ÷ revenue. Net margin = net profit ÷ revenue. * = unaudited quarter. Consolidated figures are shown when the company files them; otherwise standalone.
Coming next in fundamentals
Arrives in Phase 2. Nothing here is estimated or filled in — we only show data we have.
- P/E, P/B, EV/EBITDA, ROE, ROCE (needs balance sheet + market cap)
- FII / DII / mutual fund split (from shareholding XBRL)
- Peer comparison